Pharmaceutical compounding (503B) is compounding pharmacies with outsourcing facilities that may manufacture large batches with or without prescriptions to be sold to healthcare facilities for office use only. 503B compounding pharmacies that provide patient-specific medications are held to higher regulatory standards. These facilities must comply with current good manufacturing practices (CGMP).
Community Discussions
Community Discussions
Dec 03, 2024
Good Manufacturing Practice
Dec 02, 2024
Manufacturing Operations
Dec 02, 2024
GAMP®
Dec 02, 2024
Biotechnology
Nov 27, 2024
Data Integrity
Nov 25, 2024
Data Integrity
Nov 21, 2024
Regulatory
Regulatory